Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
Korean Journal of Rehabilitation Nursing ; : 49-60, 2022.
Article in English | WPRIM | ID: wpr-969199

ABSTRACT

Purpose@#This study aimed to investigate the psychosocial factors that affect resilience, social support, uncertainty, and depression on rehabilitation adherence in post-acute stroke patients. @*Methods@#Data were collected from 2019 September 2 to 2020 February 4 using structured questionnaires. Participants were 124 patients who visited a university-affiliated hospital in C city. Using SPSS/WIN 21.0 program, the data were analyzed with independent t-test, one-way ANOVA, Scheffé ́ test, Pearson’s correlation coefficient, and stepwise multiple regression. @*Results@#Rehabilitation adherence among stroke patients was positively correlated with resilience (r=.38, p<.001), social support (r=.43, p<.001), and negatively correlated with uncertainty (r=-.28, p=.002). The most influencing factor of rehabilitation adherence among stroke patients was inconvenience in daily life (β=.29, p=.001), resilience (β=.25, p=.012), social support (β=.23, p=.021), activities of daily living (β=.17, p=.038), and uncertainty (β=-.22, p=.017). The relevant variables have a 30.6% influence (F=11.85, p<.001) on the rehabilitation adherence of stroke patients. @*Conclusion@#Nursing professionals should pay attention to providing personalized and targeted approaches to maximize stroke patients’ resilience and social support and reduce their uncertainty. There is a need to provide and activate integrated programs that identify and link family and community support systems.

2.
Psychiatry Investigation ; : 85-91, 2022.
Article in English | WPRIM | ID: wpr-926907

ABSTRACT

Objective@#The aim of this study was to assess the psychosocial characteristics of the employees working at a university hospital and investigated the factors affecting their quality of life (QOL) under COVID-19. @*Methods@#This study enrolled 1,191 healthcare workers from a university hospital, including doctors, nurses, administrative officer and technicians. Besides demographic information, depression, anxiety, somatization, insomnia, resilience, and QOL were assessed. @*Results@#The nurses presented significantly higher scores for anxiety, depression and showed significantly higher insomnia scores and significantly lower resilience scores. The occupations showed significant differences in the QOL and sub-groups, including the overall quality of life and general health (F=4.774, p<0.001), psychological domain (F=6.230, p<0.001), and environment domain (F=5.254, p<0.001). There was a positive correlation between the QOL and resilience (r=0.608, p<0.01). However, depression (r=-0.502, p<0.01), anxiety (r=-0.425, p<0.01), somatization (r=-0.364, p<0.01), and insomnia (r=-0.385, p<0.01) showed negative correlations with the QOL. Resilience was the most important factor influencing the QOL. @*Conclusion@#The results of this study showed that low resilience adversely affected the QOL and the mental health of the healthcare workers, which consequently had a direct effect on the quality of medical care given to patients.

3.
Psychiatry Investigation ; : 332-339, 2021.
Article in English | WPRIM | ID: wpr-903170

ABSTRACT

Objective@#Coronavirus disease 2019 (COVID-19) has psychological effects such as anxiety and depression as well as direct infection in people. The Fear of COVID-19 scale is a scale that can measure anxiety related to COVID-19 in a short time. The purpose of this study was to verify the reliability and validity the Korean version of Fear of COVID-19 scale (KF-COVID-19S). @*Methods@#The data of total 186 normal adults and 17 patients were finally used for the statistical analysis. For internal consistency, Cronbach’s α was calculated. For concurrent and discriminant validity, the correlations with the Hospital Anxiety and Depression scale (HADS), Patient Health Questionnaire-15 (PHQ-15), World Health Organization Quality of Life Assessment Instrument Brief Form (WHOQOLBREF) were analyzed. For construct validity, exploratory and confirmatory factor analysis were conducted. @*Results@#Cronbach alpha was 0.88. The two-factor model (factor 1: Physical fear, factor 2: Emotional fear) showed significantly positive correlations and appeared to be “good” fitness (CFI=0.906, IFI=0.907, NFI=0.902). @*Conclusion@#The KF-COVID-19S can be a useful scale that can measure the physical and emotional fears associated with COVID-19 in a short time. Because the psychiatric patients are a more vulnerable group to the fear, it is thought that the KF-COVID-19S will help to determine the patient’s level of anxiety and make a therapeutic plan for the underlying mental disorder.

4.
Psychiatry Investigation ; : 332-339, 2021.
Article in English | WPRIM | ID: wpr-895466

ABSTRACT

Objective@#Coronavirus disease 2019 (COVID-19) has psychological effects such as anxiety and depression as well as direct infection in people. The Fear of COVID-19 scale is a scale that can measure anxiety related to COVID-19 in a short time. The purpose of this study was to verify the reliability and validity the Korean version of Fear of COVID-19 scale (KF-COVID-19S). @*Methods@#The data of total 186 normal adults and 17 patients were finally used for the statistical analysis. For internal consistency, Cronbach’s α was calculated. For concurrent and discriminant validity, the correlations with the Hospital Anxiety and Depression scale (HADS), Patient Health Questionnaire-15 (PHQ-15), World Health Organization Quality of Life Assessment Instrument Brief Form (WHOQOLBREF) were analyzed. For construct validity, exploratory and confirmatory factor analysis were conducted. @*Results@#Cronbach alpha was 0.88. The two-factor model (factor 1: Physical fear, factor 2: Emotional fear) showed significantly positive correlations and appeared to be “good” fitness (CFI=0.906, IFI=0.907, NFI=0.902). @*Conclusion@#The KF-COVID-19S can be a useful scale that can measure the physical and emotional fears associated with COVID-19 in a short time. Because the psychiatric patients are a more vulnerable group to the fear, it is thought that the KF-COVID-19S will help to determine the patient’s level of anxiety and make a therapeutic plan for the underlying mental disorder.

5.
Journal of Menopausal Medicine ; : 1-4, 2017.
Article in English | WPRIM | ID: wpr-222384

ABSTRACT

We are rapidly becoming an aging society, with the ongoing increase in challenges of the elderly. The age-related cognitive decline in accordance with aging society is of major importance in public health. Recent studies have proved the impacts of sex-steroid hormone on the brain; compliant with aging, menopause and decrease in estrogen have an effect on the occurrence and prevention of Alzheimer's disease. A new hypothesis states that Alzheimer's disease is a postmenopausal dementia, and is a negative form of estrogen deficiency. In this review article, we reckoned the cause of postmenopausal Alzheimer's disease. We further investigated new cell therapies for postmenopausal Alzheimer's disease, which are under development in some pharmaceutical companies. One remedy is cell therapy that inhibits the amyloid beta formation, and the other is the umbilical cord blood derived mesenchymal stem cell therapy.


Subject(s)
Aged , Female , Humans , Aging , Alzheimer Disease , Amyloid , Brain , Cell- and Tissue-Based Therapy , Dementia , Estrogens , Fetal Blood , Menopause , Mesenchymal Stem Cells , Public Health , Stem Cells
6.
Journal of Menopausal Medicine ; : 71-75, 2016.
Article in English | WPRIM | ID: wpr-65940

ABSTRACT

The incidence of postmenopausal diseases increases with the age of women. In this review, we introduce cell therapy products, a new treatment for postmenopausal osteoporosis, which often occurs in postmenopausal women. We also figure out the trends of research on cell therapy products and emphasize the necessity and importance of this research for researchers and postmenopausal women. Finally, we suggest the direction for improvement of postmenopausal osteoporosis and research on cell therapy products. We investigated which medication have been used so far. We also examined the development and technical problems of technologies that are currently in use.


Subject(s)
Female , Humans , Cell- and Tissue-Based Therapy , Incidence , Menopause , Osteoporosis, Postmenopausal , Stem Cells
SELECTION OF CITATIONS
SEARCH DETAIL